Coagadex Approval History
- FDA approved: Yes (First approved October 20th, 2015)
- Brand name: Coagadex
- Generic name: coagulation factor X (human)
- Dosage form: Injection
- Company: Bio Products Laboratory Limited
- Treatment for: Hereditary Factor X Deficiency
Coagadex (coagulation factor X (human)) is a human factor X concentrate for the treatment of hereditary factor X deficiency.
Hereditary factor X deficiency is a rare bleeding disorder caused by a lack of clotting factor X in the blood. Coagadex is a plasma-derived blood coagulation factor X concentrate used to treat patients 12 years and older with mild hereditary factor X deficiency for the control of bleeding episodes, and perioperative management of bleeding.
Allergic type hypersensitivity reactions, including anaphylaxis, are possible with Coagadex. Patients should stop treatment and contact their healthcare provider right away if they experience any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash or hives. Coagadex is contraindicated in patients with known hypersensitivity to any of the components of the product.
Coagadex is made from human plasma and may contain infectious agents such as viruses and, theoretically, the Creutzfeldt-Jakob disease agent. No cases of transmission of viral diseases, vCJD or CJD, have been associated with the use of Coagadex.
In clinical studies, the most common side effects (frequency ≥5% of subjects) of Coagadex were infusion site erythema, infusion site pain, fatigue and back pain.
Development History and FDA Approval Process for Coagadex
|Oct 20, 2015||FDA Approves Coagadex (coagulation factor X (human)) for Hereditary Factor X Deficiency|
|May 27, 2015||FDA Accepts BPL’s Amended BLA Submission for Coagadex (Coagulation Factor X, Human)|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.